Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-65p3f3sPhase 4Not yet recruiting
Phase 4, randomised, double-blind trial of lidocaine and ropivacaine in thyroid neoplasm, papillary thyroid cancer (PTC), anaplastic thyroid cancer (ATC) and 1 more (4 arms), sponsored by Hospital São Domingos. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-65p3f3s.